Use of intravenous polymyxin B during continuous venovenous hemodialysis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 4, 2004, Pages 340-341

  Sarria, J C ^a   Angulo Pernett, F ^a   Kimbrough, R C ^a   McVay, C S ^a   Vidal, A M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CILASTATIN; CIPROFLOXACIN; COLISTIN; IMIPENEM; PIPERACILLIN; POLYMYXIN B; SULBACTAM; TAZOBACTAM; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; EOSINOPHILIA; ERYTHEMA; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; TRAFFIC ACCIDENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; BACTEREMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MALE; MULTIPLE TRAUMA; POLYMYXIN B; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 2442663926     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1106-8     Document Type: Article

References (13)

1. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L (2003) Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit Care 7:R78-83
2. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008-1011
3. Kunin CM (1967) A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels. Ann Intern Med 67:151-158
4. MacKay DN, Kaye D (1964) Serum concentrations of colistin in patients with normal and impaired renal function. N Engl J Med 270:394-397
5. Goodwin NJ, Friedman EA (1968) The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels. Ann Intern Med 68:984-994
6. Package insert (2002) Coly-Mycin® M parenteral (colistimethate for injection, USP). Parkedale Pharmaceuticals, Rochester, MI, USA
7. Hoeprich PD (1970) The polymyxins. Med Clin North Am 54:1257-1265
8. Evans ME, Feola DJ, Rapp RP (1999) Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 33:960-967
9. Curtis JR, Eastwood JB (1968) Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis. Br Med J 1:484-485
10. Greenberg PA, Sanford JP (1967) Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Tetracycline, chloramphenicol, kanamycin, and colistimethate. Ann Intern Med 66:465-470
11. Duncan DA (1973) Colistin toxicity. Neuromuscular and renal manifestations. Two cases treated by hemodialysis. Minn Med 56:31-35
12. Swick HM, Maxwell E, Charache P, Levin S (1969) Peritoneal dialysis in colistin intoxication: report of a case. J Pediatr 74:976-980
13. Amsden GW (2000) Tables of antimicrobial agent pharmacology. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, PA, pp 578-579